[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Hib Vaccine Market Report 2018

February 2018 | 98 pages | ID: UEEEDC5EE21QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Hib Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
with sales (volume), revenue (value), market share and growth rate of Hib Vaccine in these regions, from 2013 to 2025 (forecast).
United States Hib Vaccine market competition by top manufacturers/players, with Hib Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novartis
  • Merck
  • Sanofi
  • GSK
  • Takeda Pharmaceutical Company Limited
  • China National Pharmaceutical Group Corporation
  • China Biotechnology Group Corporation
  • Bio Kang Tai
  • Walvax Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Type I
  • Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Hib Vaccine Market Report 2018

1 HIB VACCINE OVERVIEW

1.1 Product Overview and Scope of Hib Vaccine
1.2 Classification of Hib Vaccine by Product Category
  1.2.1 United States Hib Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Hib Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3
  1.2.4
1.3 United States Hib Vaccine Market by Application/End Users
  1.3.1 United States Hib Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Research & Academic Laboratories
  1.3.4 Pharmaceutical & Biotechnology Companies
  1.3.5 Others
1.4 United States Hib Vaccine Market by Region
  1.4.1 United States Hib Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Hib Vaccine Status and Prospect (2013-2025)
  1.4.3 Southwest Hib Vaccine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Hib Vaccine Status and Prospect (2013-2025)
  1.4.5 New England Hib Vaccine Status and Prospect (2013-2025)
  1.4.6 The South Hib Vaccine Status and Prospect (2013-2025)
  1.4.7 The Midwest Hib Vaccine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Hib Vaccine (2013-2025)
  1.5.1 United States Hib Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 United States Hib Vaccine Revenue and Growth Rate (2013-2025)

2 UNITED STATES HIB VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hib Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Hib Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Hib Vaccine Average Price by Players/Suppliers (2013-2018)
2.4 United States Hib Vaccine Market Competitive Situation and Trends
  2.4.1 United States Hib Vaccine Market Concentration Rate
  2.4.2 United States Hib Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hib Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HIB VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Hib Vaccine Sales and Market Share by Region (2013-2018)
3.2 United States Hib Vaccine Revenue and Market Share by Region (2013-2018)
3.3 United States Hib Vaccine Price by Region (2013-2018)

4 UNITED STATES HIB VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Hib Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Hib Vaccine Revenue and Market Share by Type (2013-2018)
4.3 United States Hib Vaccine Price by Type (2013-2018)
4.4 United States Hib Vaccine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HIB VACCINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Hib Vaccine Sales and Market Share by Application (2013-2018)
5.2 United States Hib Vaccine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HIB VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hib Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Hib Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Hib Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GSK
  6.4.2 Hib Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GSK Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Takeda Pharmaceutical Company Limited
  6.5.2 Hib Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Takeda Pharmaceutical Company Limited Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 China National Pharmaceutical Group Corporation
  6.6.2 Hib Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 China National Pharmaceutical Group Corporation Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 China Biotechnology Group Corporation
  6.7.2 Hib Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 China Biotechnology Group Corporation Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bio Kang Tai
  6.8.2 Hib Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio Kang Tai Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Walvax Biotechnology
  6.9.2 Hib Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Walvax Biotechnology Hib Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 HIB VACCINE MANUFACTURING COST ANALYSIS

7.1 Hib Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hib Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hib Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hib Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HIB VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Hib Vaccine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Hib Vaccine Sales Volume Forecast by Type (2018-2025)
11.3 United States Hib Vaccine Sales Volume Forecast by Application (2018-2025)
11.4 United States Hib Vaccine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Hib Vaccine
Figure United States Hib Vaccine Market Size (K Units) by Type (2013-2025)
Figure United States Hib Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Type I Product Picture
Figure Type II Product Picture
Figure United States Hib Vaccine Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Hib Vaccine by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Research & Academic Laboratories Examples
Table Key Downstream Customer in Research & Academic Laboratories
Figure Pharmaceutical & Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical & Biotechnology Companies
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Hib Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Hib Vaccine Sales (K Units) and Growth Rate (2013-2025)
Figure United States Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Hib Vaccine Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Hib Vaccine Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Hib Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Hib Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Hib Vaccine Sales Share by Players/Suppliers
Figure United States Hib Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Hib Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Hib Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Hib Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Hib Vaccine Revenue Share by Players/Suppliers
Table United States Market Hib Vaccine Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Hib Vaccine Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Hib Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Hib Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hib Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hib Vaccine Product Category
Table United States Hib Vaccine Sales (K Units) by Region (2013-2018)
Table United States Hib Vaccine Sales Share by Region (2013-2018)
Figure United States Hib Vaccine Sales Share by Region (2013-2018)
Figure United States Hib Vaccine Sales Market Share by Region in 2017
Table United States Hib Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Hib Vaccine Revenue Share by Region (2013-2018)
Figure United States Hib Vaccine Revenue Market Share by Region (2013-2018)
Figure United States Hib Vaccine Revenue Market Share by Region in 2017
Table United States Hib Vaccine Price (USD/Unit) by Region (2013-2018)
Table United States Hib Vaccine Sales (K Units) by Type (2013-2018)
Table United States Hib Vaccine Sales Share by Type (2013-2018)
Figure United States Hib Vaccine Sales Share by Type (2013-2018)
Figure United States Hib Vaccine Sales Market Share by Type in 2017
Table United States Hib Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Hib Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Hib Vaccine by Type (2013-2018)
Figure Revenue Market Share of Hib Vaccine by Type in 2017
Table United States Hib Vaccine Price (USD/Unit) by Types (2013-2018)
Figure United States Hib Vaccine Sales Growth Rate by Type (2013-2018)
Table United States Hib Vaccine Sales (K Units) by Application (2013-2018)
Table United States Hib Vaccine Sales Market Share by Application (2013-2018)
Figure United States Hib Vaccine Sales Market Share by Application (2013-2018)
Figure United States Hib Vaccine Sales Market Share by Application in 2017
Table United States Hib Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States Hib Vaccine Sales Growth Rate by Application (2013-2018)
Table Novartis Basic Information List
Table Novartis Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Hib Vaccine Sales Growth Rate (2013-2018)
Figure Novartis Hib Vaccine Sales Market Share in United States (2013-2018)
Figure Novartis Hib Vaccine Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Hib Vaccine Sales Growth Rate (2013-2018)
Figure Merck Hib Vaccine Sales Market Share in United States (2013-2018)
Figure Merck Hib Vaccine Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Hib Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi Hib Vaccine Sales Market Share in United States (2013-2018)
Figure Sanofi Hib Vaccine Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Hib Vaccine Sales Growth Rate (2013-2018)
Figure GSK Hib Vaccine Sales Market Share in United States (2013-2018)
Figure GSK Hib Vaccine Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Takeda Pharmaceutical Company Limited Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Company Limited Hib Vaccine Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Company Limited Hib Vaccine Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceutical Company Limited Hib Vaccine Revenue Market Share in United States (2013-2018)
Table China National Pharmaceutical Group Corporation Basic Information List
Table China National Pharmaceutical Group Corporation Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure China National Pharmaceutical Group Corporation Hib Vaccine Sales Growth Rate (2013-2018)
Figure China National Pharmaceutical Group Corporation Hib Vaccine Sales Market Share in United States (2013-2018)
Figure China National Pharmaceutical Group Corporation Hib Vaccine Revenue Market Share in United States (2013-2018)
Table China Biotechnology Group Corporation Basic Information List
Table China Biotechnology Group Corporation Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure China Biotechnology Group Corporation Hib Vaccine Sales Growth Rate (2013-2018)
Figure China Biotechnology Group Corporation Hib Vaccine Sales Market Share in United States (2013-2018)
Figure China Biotechnology Group Corporation Hib Vaccine Revenue Market Share in United States (2013-2018)
Table Bio Kang Tai Basic Information List
Table Bio Kang Tai Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bio Kang Tai Hib Vaccine Sales Growth Rate (2013-2018)
Figure Bio Kang Tai Hib Vaccine Sales Market Share in United States (2013-2018)
Figure Bio Kang Tai Hib Vaccine Revenue Market Share in United States (2013-2018)
Table Walvax Biotechnology Basic Information List
Table Walvax Biotechnology Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Walvax Biotechnology Hib Vaccine Sales Growth Rate (2013-2018)
Figure Walvax Biotechnology Hib Vaccine Sales Market Share in United States (2013-2018)
Figure Walvax Biotechnology Hib Vaccine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hib Vaccine
Figure Manufacturing Process Analysis of Hib Vaccine
Figure Hib Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hib Vaccine Major Players/Suppliers in 2017
Table Major Buyers of Hib Vaccine
Table Distributors/Traders List
Figure United States Hib Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Hib Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Hib Vaccine Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Hib Vaccine Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Hib Vaccine Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Hib Vaccine Sales Volume (K Units) Forecast by Type in 2025
Table United States Hib Vaccine Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Hib Vaccine Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Hib Vaccine Sales Volume (K Units) Forecast by Application in 2025
Table United States Hib Vaccine Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Hib Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Hib Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Hib Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications